Search alternatives:
"javaria" » "javanica" (Expand Search), "javadian" (Expand Search), "navarria" (Expand Search)
"bavarian" » "bazarian" (Expand Search), "bharian" (Expand Search), "bivariat" (Expand Search), "bavarians" (Expand Search), "baharian" (Expand Search), "bamarian" (Expand Search)
"varian" » "varians" (Expand Search), "harian" (Expand Search), "marian" (Expand Search)
"variant" » "varianst" (Expand Search), "hariant" (Expand Search), "mariant" (Expand Search), "variants" (Expand Search), "invariant" (Expand Search), "variance" (Expand Search)
"ovarian" » "ovarians" (Expand Search), "oharian" (Expand Search), "omarian" (Expand Search)
"javaria" » "javanica" (Expand Search), "javadian" (Expand Search), "navarria" (Expand Search)
"bavarian" » "bazarian" (Expand Search), "bharian" (Expand Search), "bivariat" (Expand Search), "bavarians" (Expand Search), "baharian" (Expand Search), "bamarian" (Expand Search)
"varian" » "varians" (Expand Search), "harian" (Expand Search), "marian" (Expand Search)
"variant" » "varianst" (Expand Search), "hariant" (Expand Search), "mariant" (Expand Search), "variants" (Expand Search), "invariant" (Expand Search), "variance" (Expand Search)
"ovarian" » "ovarians" (Expand Search), "oharian" (Expand Search), "omarian" (Expand Search)
-
1
Targeting the Bromodomain-containing protein 4 in ovarian clear cell carcinoma
Published 2017“…Ovarian clear cell carcinoma (OCCC) is the second most common histopathological subtype of ovarian carcinoma (OC), making up 5-25% of all OC. …”
Get full text
Final Year Project (FYP) -
2
First-line chemotherapy for advanced ovarian cancer: paclitaxel, cisplatin and the evidence
Published 1998Journal article -
3
Neutron contamination of Varian Clinac iX 10 MV photon beam using Monte Carlo simulation
Published 2018“…This study concerns the simulation of neutron contamination emitted from Varian Clinac iX 10 MV using Monte Carlo code system. …”
Get full text
Get full text
Journal Article -
4
Using Sequenom to identify KRAS mutations in an Asian cohort of ovarian mucinous cancer
Published 2014“…While there are distinct differences between mucinous epithelial ovarian cancer (mEOC) and the other subtypes of EOC, a standard treatment regimen is followed for all EOC histotypes. …”
Get full text
Final Year Project (FYP) -
5
The emergence of DNAM-1 as the facilitator of NK cell-mediated killing in ovarian cancer
Published 2025“…Introduction: Ovarian cancer (OC) is the sixth most common malignancy in women and the poor 5-year survival emphasises the need for novel therapies. …”
Journal article -
6
Inferring structural variant cancer cell fraction
Published 2020“…We present SVclone, a computational method for inferring the cancer cell fraction of structural variant (SV) breakpoints from whole-genome sequencing data. …”
Journal article -
7
In vitro evaluation of oral contraceptives on long-tailed macaque (Macaca fascicularis) primary ovarian cells
Published 2024“…The present study aims to investigate the effect of oral contraceptives (Nordette, Noriday, and Ella) on long-tailed macaque ovarian cells. We determine the cell viability and cytotoxicity as well as the morphological changes of the drugs on long-tailed macaque ovarian cells using the MTT assay, Acridine orange/propidium iodide double staining method, morphological examination, and the 4, 6-diamidino-2-phenylindole (DAPI) staining method. …”
Get full text
Article -
8
Targeting the GPI transamidase subunit GPAA1 abrogates the CD24 immune checkpoint in ovarian cancer
Published 2024“…CD24 is frequently overexpressed in ovarian cancer and promotes immune evasion by interacting with its receptor Siglec10, present on tumor-associated macrophages, providing a "don't eat me" signal that prevents targeting and phagocytosis by macrophages. …”
Get full text
Journal Article -
9
Marine predator algorithm and related variants: A systematic review
Published 2025Get full text
Article -
10
Fast and accurate variant identification tool for sequencing-based studies
Published 2024“…Results We present QuickVariants, a bioinformatics tool that effectively summarizes variant information from read alignments and identifies variants. …”
Get full text
Article -
11
ranscriptome profile and gene expression during different ovarian maturation stages of Macrobrachium rosenbergii (De Man, 1879)
Published 2024“…The differentially expressed genes (DEG) analysis conducted in this study led to identifying cyclin B, insulin receptor (IR), oestrogen sulfotransferase (ESULT) and vitellogenin (Vg), which are critical in ovarian maturation. Nevertheless, some M. rosenbergii ovarian maturation-related genes, such as small ubiquitin-like modifier (SUMO)-activating enzyme subunit 1, E3 ubiquitin-protein ligase RNF25, and neuroparsin, were first identified in this study. …”
Get full text
Article -
12
Functional characterisation guides classification of novel BAP1 germline variants
Published 2021“…In this study, we functionally characterise known BAP1 pathogenic and likely benign germline variants out of these six patients to aid in the evaluation and classification of unknown BAP1 germline variants. …”
Get full text
Journal Article -
13
-
14
Double trouble: Predicting new variant counts across two heterogeneous populations
Published 2025“…We provide the first predictor for the number of new shared variants and new total variants that can handle heterogeneity in multiple populations. …”
Get full text
Thesis -
15
Molecular and biochemical characterisation of human casein kinase I alpha splice variants
Published 2009“…It has been shown in mammalian tissues that CKI alpha exists in two or three alternatively spliced variants (Rowles et al., 1991; Zhang et al., 1996; Kuret et al., 1997). …”
Get full text
Thesis -
16
Emergence and spread of two SARS-CoV-2 variants of interest in Nigeria
Published 2023“…In this study, we integrated genomic and travel data to investigate the emergence and spread of the SARS-CoV-2 B.1.1.318 and B.1.525 (Eta) variants of interest in Nigeria and the wider Africa region. …”
Journal article -
17
The impact of evolving SARS-CoV-2 mutations and variants on COVID-19 vaccines
Published 2022“…Data from clinical trials and real-world evidence suggest that current vaccines remain highly effective against the alpha variant (B.1.1.7), while some vaccines have reduced efficacy and effectiveness against symptomatic disease caused by the beta variant (B.1.351) and the delta variant (B.1.617.2); however, effectiveness against severe disease and hospitalization caused by delta remains high. …”
Get full text
Article -
18
Reconciling founder variant multiplicity of HIV-1 infection with the rate of CD4+ decline
Published 2024“…HIV-1 transmission precipitates a stringent genetic bottleneck, with 75% of new infections initiated by a single genetic variant. Where multiple variants initiate infection, recipient set point viral load (SpVL) and the rate of CD4+ 4 T cell decline may be elevated, but these findings remain inconsistent. …”
Journal article -
19
Southeast Asia initiative to combat SARS-CoV-2 variants (SEACOVARIANTS) consortium
Published 2024“…A strong and effective COVID-19 and future pandemic responses rely on global efforts to carry out surveillance of infections and emerging SARS-CoV-2 variants and to act accordingly in real time. Many countries in Southeast Asia lack capacity to determine the potential threat of new variants, or other emerging infections. …”
Journal article -
20
Germline breast cancer susceptibility genes, tumor characteristics, and survival
Published 2022Subjects: Get full text
Journal Article